Hansoh Pharmaceutical Group Company Limited (HNSPF)
OTCMKTS
· Delayed Price · Currency is USD
3.450
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
HNSPF Revenue
In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B CNY with 21.35% growth. Hansoh Pharmaceutical Group Company had revenue of 5.76B in the half year ending December 31, 2024, with 16.32% growth.
Revenue
12.26B CNY
Revenue Growth
+21.35%
P/S Ratio
10.61
Revenue / Employee
1.36M CNY
Employees
8,989
Market Cap
17.82B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |